
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.320 | 5.320 | 0.000 |
Shares | 94.680 | 94.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.887 | 18.048 |
Price to Book | 5.891 | 3.312 |
Price to Sales | 2.950 | 2.206 |
Price to Cash Flow | 15.543 | 13.535 |
Dividend Yield | 2.750 | 2.927 |
5 Years Earnings Growth | 6.726 | 9.084 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.460 | 30.832 |
Industrials | 19.470 | 15.773 |
Consumer Defensive | 15.100 | 12.771 |
Financial Services | 12.530 | 21.604 |
Basic Materials | 10.080 | 8.188 |
Consumer Cyclical | 4.610 | 5.335 |
Technology | 1.750 | 3.408 |
Number of long holdings: 24
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 14.30 | 75.39 | +0.65% | |
Roche Holding Participation | CH0012032048 | 11.88 | 260.30 | -0.27% | |
Novartis | CH0012005267 | 10.55 | 101.16 | -0.37% | |
Zurich Insurance Group | CH0011075394 | 8.09 | 584.40 | +0.83% | |
Lonza Group | CH0013841017 | 6.78 | 567.00 | -0.46% | |
ABB | CH0012221716 | 6.06 | 53.68 | -1.29% | |
Givaudan | CH0010645932 | 5.65 | 3,370.00 | -0.33% | |
Sika | CH0418792922 | 3.89 | 185.50 | -1.07% | |
Belimo Holding | CH1101098163 | 3.77 | 880.0 | -0.73% | |
Partners Group | CH0024608827 | 3.77 | 1,097.50 | -1.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 922.49M | 0.63 | 2.74 | 1.80 | ||
BCV PENSION 40 AP | 669.42M | 1.31 | 3.77 | 3.07 | ||
Synchrony All Caps CH A | 582.1M | 2.71 | 0.59 | 6.05 | ||
Synchrony Small Mid Caps CH I | 190.05M | 9.06 | 0.95 | 7.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review